ArriVent BioPharma
AVBP
AVBP
99 hedge funds and large institutions have $732M invested in ArriVent BioPharma in 2025 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 25 increasing their positions, 30 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
99
Holders Change
+16
Holders Change %
+19.28%
% of All Funds
1.33%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.08%
New
26
Increased
25
Reduced
30
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
IAM
Infinitum Asset Management
Fort Lauderdale,
Florida
|
+$29.4M |
| 2 |
SCM
Suvretta Capital Management
New York
|
+$23.4M |
| 3 |
SL
Siren LLC
Greenwich,
Connecticut
|
+$15.2M |
| 4 |
F1I
Fund 1 Investments
Rincon,
Puerto Rico
|
+$11.5M |
| 5 |
CLG
Cooperman Leon G
|
+$9.17M |
Top Sellers
| 1 |
BlackRock
New York
|
-$6.56M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$2.52M |
| 3 |
OCA
Octagon Capital Advisors
New York
|
-$2.47M |
| 4 |
Two Sigma Investments
New York
|
-$765K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$674K |
